Prevention of bone disease and early detection of impending fractures in multiple myeloma patients can reduce morbidity and mortality: the necessity of interdisciplinary state-of-the-art treatment

Benzer Materyaller

• Analysis of skeletal pain, general symptoms and patient-reported outcome measures and their value in detecting symptomatic progression – An interdisciplinary prospective study in patients with multiple myeloma
  Yazar:: Carlotta Pietsch, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-06-01)
• Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?
  Yazar:: Engelhardt, Monika, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
  Yazar:: Engelhardt, Monika, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
  Yazar:: Shoumariyeh, Khalid, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
  Yazar:: Bruno, Benedetto, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)